Link Made Between Human Growth Hormone, Bone Quality In Mice

March 30, 1998

EDITORS: A black-and-white slide comparing magnified cross-sections of bone in experimental and control mice is available on request.

ANN ARBOR---Laboratory mice which have been genetically altered to produce human growth hormone grow to be 25-30 percent larger than normal mice---with much of that size difference coming from bigger bones, according to University of Michigan researchers. The trade-off for bigger bones in adolescence, however, appears to be poorer bone quality, increased brittleness and less resistance to fractures as mice age.

Steven A. Goldstein, professor of surgery in the U-M Medical School and professor of biomedical engineering in the U-M College of Engineering, suggested his results, while preliminary, raise a "red flag" on the increasing use of human growth hormone in short children and as a "fountain-of-youth drug" in the elderly.

The study by Kuo-Fung Tseng, now with the Veterans General Hospital in Taipei, Taiwan, and Goldstein is published in the April 1998 issue of the Journal of Bone and Mineral Research.

The U-M study was designed to learn more about complex feedback mechanisms between genes and mechanical forces, which control how bones grow and develop. "This balance between structure and function has evolved over years of mammalian evolutionary development to produce bone strong enough for an animal's daily activity, but not so strong that it requires too much energy to grow and maintain," Goldstein said. "Disturbances in this well-balanced relationship could result in bone fragility diseases, such as osteoporosis."

Thirty-nine of the male mice in the U-M study were transgenic---meaning that their DNA contained both mouse and human genes. These mice were able to secrete large amounts of human growth factor, because the human gene which triggers production of this hormone had been inserted into their DNA during the fertilized egg stage of development. Thirty-six male control mice in the study were littermates of the experimental mice, but did not carry the gene for human growth hormone.

According to Goldstein, mean body weights of the two groups were identical until the puberty growth spurt, which begins when mice are between four and nine weeks old. "After 12 weeks of age, the transgenic mice were 25 to 30 percent larger in body weight and size than their littermate controls," Goldstein said. "At 16 weeks, the femurs or long upper leg bones of the experimental mice were significantly larger, thicker and longer than those of the control mice."

To test for strength and fracture resistance, Tseng and Goldstein removed femurs from both groups of mice and bent them in a mechanical testing device until they broke. While leg bones from transgenic mice were stronger at 16 weeks of age, the smaller leg bones from control mice were just as strong or even stronger by about 24 weeks.

"We saw a continual degradation of mechanical properties in the bones of transgenic mice as they aged," Goldstein said. When they examined cross-sections of bone under a microscope, Tseng and Goldstein found the transgenic mice had more cartilage, woven bone and porous areas in their bone tissue and a lower ash content than did the same bones in age-matched control mice. They also found that transgenic mice had higher levels of bone resorption as they aged than did normal mice.

Goldstein said more research will be necessary to pin down exactly how growth hormone upsets the natural balance between structure and function in developing mouse bone.

"It may be that inferior bone quality is a direct result of too-rapid bone growth or the presence of growth hormone itself," Goldstein said. "We believe it's more likely that the animal's adaptive feedback mechanism, sensing more stress on bones during the growth spurt, increases bone growth to restore a balance between structure and function. After puberty, the mechanism senses less stress and triggers increased bone resorption to restore the balance again. In the process of maintaining whole bone structural integrity, the mechanical integrity of tissue may be sacrificed."

"While we don't yet understand exactly how this mechanism works in mice, much less people, it appears that the same process which makes bone grow larger is doing so at the expense of bone quality," Goldstein said. "Until we know more, I would be cautious about prescribing human growth hormone, especially to individuals without a specific medical need, without giving any thought to the possible consequences."

The study was funded by the National Institutes of Health and the Frederick Fischer Endowment for pediatric orthopedic research at the U-M. Jeffrey F. Bonadio, a senior associate research scientist in the U-M Medical School, also was a key collaborator in the research program.

# # # # # #
-end-


University of Michigan

Related Growth Hormone Articles from Brightsurf:

Growth hormone plays key role in early puberty, breast cancer risk
Girls who enter puberty early in life--as measured by early breast development and age of first menstrual period--have a longer window of susceptibility to breast cancer.

Human growth hormone treatment after ACL injury may prevent loss of muscle strength
A new study finds the use of HGH treatment in patients that have undergone ACL reconstructive surgery may prevent the loss of muscle strength and weakness.

Liver surgery success boosted by growth hormone
Growth hormone has been identified as playing a key role in reducing inflammation and increasing survival rates following liver surgery.

Growth hormone acts to prevent weight loss
A Brazilian study shows that, like leptin, growth hormone contributes directly to energy conservation when the body loses weight.

Cost savings from growth hormone insurance strategies not passed on to patients
Increasingly aggressive insurance strategies have lowered the total costs and insurance costs of growth hormone drugs, but those savings are not being passed on to patients, according to new research to be presented Sunday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

Patients bear increased financial burden for growth hormone treatment despite FDA approval
Despite an FDA approval of growth hormone treatment for children with idiopathic short stature (ISS), the mean cost burden to patients and their families has increased over time.

Growth hormone may provide new hope for stroke survivors
Less fatigue and better recovery of cognitive abilities such as learning and memory.

FASEB Science Research Conference: Growth Hormone/Prolactin
This SRC will bring together international scientists from academia and industry for lively discussions on the latest developments in the growth hormone (GH)/prolactin (PRL) family of hormones and their clinical applications.

Low thyroid hormone before birth alters growth and development of fetal pancreas
Levels of thyroid hormone in babies influences insulin-secreting cells of the pancreas, according to a new study published in The Journal of Physiology.

When should doctors treat short children and teens with growth hormone?
When is it appropriate to treat short children with growth hormone?

Read More: Growth Hormone News and Growth Hormone Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.